Predictive Factors of Progression to Carcinoma in Vocal Fold Leucoplakia
DOI:
https://doi.org/10.34631/sporl.1057Keywords:
Leucoplakia, laryngeal cancer, vocal fold premalignant lesionAbstract
Objectives: To assess possible risk factors for progression in vocal fold leucoplakia.
Study Design: Observational retrospective study.
Material and Methods: Clinical data analysis of every patient submitted to microlaryngoscopy (MLS) with biopsy, excisional whenever possible, of vocal fold leucoplakia from January 2010 to December 2020 in the Otorhinolaryngology department of a tertiary hospital centre.
Results: One or more MLS were performed on 163 patients. Histological results were squamous cell carcinoma in 50 (30,7%), pre-malignant lesion in 68 (41,7%) and benign lesion in 45 (27,6%). Patients with a more severe dysplasia grade on the first biopsy had higher rates of malignant transformation (p=0,017). On the other hand, age, gender, tobacco or alcohol consumption, smoking cessation or the presence of gastroesophageal reflux disease weren’t associated with the progression to carcinoma.
Conclusion: The main risk factor for progression to carcinoma is the histological grade on the first biopsy.
References
Obid R, Redlich M, Tomeh C. The treatment of laryngeal cancer. Oral Maxillofac Surg Clin North Am. 2019 Feb;31(1):1-11. doi: 10.1016/j.coms.2018.09.001.
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017 Jan;67(1):31-50. doi: 10.3322/caac.21386.
Frangez I, Gale N, Luzar B. The interpretation of leukoplakia in laryngeal pathology. Acta Otolaryngol Suppl. 1997;527:142-4. doi: 10.3109/00016489709124058.
Isenberg JS, Crozier DL, Dailey SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol. 2008 Jan;117(1):74-9. doi: 10.1177/000348940811700114.
Garrel R, Uro Coste E, Costes-Martineau V, Woisard V, Atallah I, Remacle M. Vocal-fold leukoplakia and dysplasia. Mini-review by the French Society of Phoniatrics and Laryngology (SFPL) Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Nov;137(5):399-404. doi: 10.1016/j.anorl.2020.01.008.
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. Editors WHO Classification of Head and Neck Tumours. [Online] WHO Classification of Tumours, 4th Edition, Volume 9. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Head-And-Neck-Tumours-2017
Lee DH, Yoon TM, Lee JK, Lim SC. Predictive factors of recurrence and malignant transformation in vocal cord leukoplakia. Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1719-24. doi: 10.1007/s00405-015-3587-8.
Sannino NJB, Mehlum CS, Grøntved ÅM, Kjaergaard T, Kiss K, Godballe C. et al. Incidence and malignant transformation of glottic precursor lesions in Denmark. Acta Oncol. 2020 May;59(5):596-602. doi: 10.1080/0284186X.2020.1730437.
Kostev K, Jacob LEC, Kalder M, Sesterhenn AM, Seidel DU. Association of laryngeal cancer with vocal cord leukoplakia and associated risk factors in 1,184 patients diagnosed in otorhinolaryngology practices in Germany. Mol Clin Oncol. 2018 May;8(5):689-693. doi: 10.3892/mco.2018.1592.
Odell E, Eckel HE, Simo R, Quer M, Paleri V, Klussmann JP. et al. European Laryngological Society position paper on laryngeal dysplasia Part I: aetiology and pathological classification. Eur Arch Otorhinolaryngol. 2021 Jun;278(6):1717-1722. doi: 10.1007/s00405-020-06403-y.
Weller MD, Nankivell PC, McConkey C, Paleri V, Mehanna HM. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis. Clin Otolaryngol. 2010 Oct;35(5):364-72. doi: 10.1111/j.1749-4486.2010.02181.x.
Theodosiou MG, Yiotakis J, Dikoglou C, Lazaris AC, Athanasiadis-Sismanis A, Xenellis J. Laryngeal dysplasia: a long-term follow-up study. J BUON. Jul-Sep 2013;18(3):683-8.
Yang SW, Chao WC, Lee YS, Chang LC, Hsieh TY, Chen TA. et al. Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery. Lasers Med Sci. 2017 Jan;32(1):19-27. doi: 10.1007/s10103-016-2078-5.
Eckel HE, Simo R, Quer M, Odell E, Paleri V, Klussmann JP. et al. European Laryngological Society position paper on laryngeal dysplasia Part II: diagnosis, treatment, and follow-up. Eur Arch Otorhinolaryngol. 2021 Jun;278(6):1723-1732. doi: 10.1007/s00405-020-06406-9.
van Hulst AM, Kroon W, van der Linden ES, Nagtzaam L, Ottenhof SR, Wegner I. et al. Grade of dysplasia and malignant transformation in adults with premalignant laryngeal lesions. Head Neck. 2016 Apr;38 Suppl 1:E2284-90. doi: 10.1002/hed.24185.
Luers JC, Sircar K, Drebber U, Beutner D. The impact of laryngeal dysplasia on the development of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014 Mar;271(3):539-45. doi: 10.1007/s00405-013-2670-2.
Gale N, Hille J, Jordan RC, Nadal A, Williams MD. Tumours of the hypopharynx, larynx, trachea and parapharyngeal space. In: AK El-Naggar, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: IARC; 2017. p. 77-104.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.